Taro Pharmaceutical Industries (TARO) Reports Improved Q2 EPS of $1.46

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) reported Q2 EPS of $1.46, versus $1.32 reported last year. Revenue for the quarter came in at $160.97 million, versus $138.25 million reported last year.

For earnings history and earnings-related data on Taro Pharmaceutical Industries Ltd. (TARO) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Paysafe Limited (PSFE) Misses Q2 EPS by 43c; offers guidance
• YETI Holdings, Inc. (YETI) Tops Q2 EPS by 12c
• Golar LNG (GLNG) reports Q2 results